稳恒磁场对家兔谷胱甘肽过氧化酶及过氧化氢酶活性的影响

目的:探讨稳恒磁场对家兔谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)活性的影响。方法:将20只家兔随机分为实验组与对照组。实验组每天进行一次磁处理,每次120min。稳恒磁场利用亥姆霍兹线圈产生,中心强度为22Gs。8周后测定两组家兔血清中GSH-Px和血液中CAT的活性。结果:实验组GSH-Px活性为(1426.50士156.72)活力单位/ml,CAT活性为(67.01士12.23)活力单位/L。对照组GSH-Px活性为(1178.25士270.36)活力单位/ml,CAT活性为(54.34士6.42)活力单位/L。实验组GSH-Px与CAT活性明显升高(P<0.05)。结论:稳恒磁场能够增强GSH-Px和CAT的活性,提高机体处理自由基的能力,增加机体的抵抗能力,具有一定的抗哀老功能。     

Lipid peroxides,vitamin E levels and glutathione peroxidase activity in serum of respiratory disease patients

The concentration of serum lipid peroxides, tocopherol and glutathione peroxidase (GPx) activity was measured in 75 patients (43 males and 32 females) of different respiratory diseases aged 15–40 years. The results were compared with the values obtained from 100 healthy persons of comparabie age. The patients of respiratory diseases showed elevated levels of lipid peroxides with concomitant reduction of tocopherol and glutathione peroxidase activity. When these patients were categorised into different groups depending on the type of the disease like pulmonary tuberculosis (PT), chronic obstructive pulmonary disease (COPD), pulmonary tuberculosis and chronic obstructive pulmonary disease (PT and COPD) and suppurative lung disease (SLD). There was no significant difference between the groups. A significant inverse relation was found between lipid peroxides versus tocopherol and glutathione peroxidase activity in patients of respiratory diseases. The results suggest the involvement of lipid peroxidation process in pulmonary damage.     

Verification of Atellica 1500 and comparison with Iris urine analyser and urine culture

IntroductionThe aims of study were to assess: 1) performance specifications of Atellica 1500, 2) comparability of Atellica 1500 and Iris, 3) the accuracy of both analysers in their ability to detect bacteria.Materials and methodsCarryover, linearity, precision, reproducibility, and limit of blank (LoB) verification were evaluated for erythrocyte and leukocyte counts. ICSH 2014 protocol was used for estimation of carryover, CLSI EP15-A3 for precision, and CLSI EP17 for LoB verification. Comparison for quantitative parameters was evaluated by Bland-Altman plot and Passing-Bablok regression. Qualitative parameters were evaluated by Weighted kappa analysis. Sixty-five urine samples were randomly selected and sent for urine culture which was used as reference method to determine the accuracy of bacteria detection by analysers.ResultsAnalytical specifications of Atellica 1500 were successfully verified. Total of 393 samples were used for qualitative comparison, while 269 for sediment urinalysis. Bland-Altman analysis showed statistically significant proportional bias for erythrocytes and leukocytes. Passing-Bablok analysis for leukocytes pointed to significant constant and minor proportional difference, while it was not performed for erythrocytes due to significant data deviation from linearity. Kappa analysis resulted in the strongest agreements for pH, ketones, glucose concentrations and leukocytes, while the poorest agreement for bacteria. The sensitivity and specificity of bacteria detection were: 91 (59-100)% and 76 (66-87)% for Atellica 1500 and 46 (17-77)% and 96 (87-100)% for Iris.ConclusionThere are large differences between Atellica 1500 and Iris analysers, due to which they are not comparable and can not be used interchangeably. While there was no difference in specificity of bacteria detection, Iris analyser had greater sensitivity.     

Diagnostic and prognostic value of the urinary excretion of beta-aminoisobutyric acid in patients with urinary bladder cancer

Urinary excretion of beta-aminoisobutyric acid (BAIB), was determined in 28 active and 12 inactive bladder cancer patients. Mean excretion of BAIB was higher in active cancer patients-187.8 mg/24 hours whereas it was 120.4 mg/24 hours in inactive cancer patients. The increased BAIB excretion in both disease groups was independent of tumour stage. BAIB appears to be a useful diagnositic aid in the assessment of bladder cancer patients.     

Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy

Diabetic nephropathy is a major cause of end stage renal disease. Increased excretion of albumin has widely been recognized as an early manifestation of diabetic nephropathy particularly in subjects with diabetes mellitus. However, certain other proteins besides albumin may be excreted in high amount during early phase of diabetic nephropathy. The serum and urinary IgG, Glycosylated hemoglobin, fructosamine and glycosylated IgG were evaluated in the present study. Thirty-two patients of Type 2 Diabetes without any complications, thirty-one patients of Type 2 Diabetes with nephropathy, twenty-six patients of non-diabetic nephropathy and forty normal healthy individuals were enrolled in this study. Subjects were grouped based on their serum creatinine level. Serum IgG, glycosylation of IgG and urinary IgG excretion were increased significantly in diabetic patients compared to healthy controls, which were further increased significantly in chronic renal failure patients with respect to the clinical stage of nephropathy. A positive correlation was observed between glycosylation of IgG and IgG excretion (R²=0.5995, 0.7114 respectively) in diabetic patients without any complications and diabetic nephropathy patients only, suggesting a significant role of IgG glycosylation in the vascular clearances of IgG during diabetic nephropathy.